Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electronic health record nudges to optimize guideline-directed medical therapy for heart failure.

Heart failure reviews·2025
Same author

Impact of Obesity on Heart Transplantation Outcomes.

Journal of the American Heart Association·2021
Same author

Trends and Outcomes of Cardiac Transplantation in the Lowest Urgency Candidates.

Journal of the American Heart Association·2021
Same author

Evaluation of Racial and Ethnic Disparities in Cardiac Transplantation.

Journal of the American Heart Association·2021
Same author

Mechanical ventilation at the time of heart transplantation and associations with clinical outcomes.

European heart journal. Acute cardiovascular care·2021
Same author

Comparative Evaluation of the Cytotoxicity of Glyphosate-Based Herbicides and Glycine in L929 and Caco2 Cells.

Frontiers in public health·2021

Related Experiment Video

Updated: Jun 4, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Predictive models for nanotoxicology: current challenges and future opportunities.

Katherine A Clark1, Ronald H White, Ellen K Silbergeld

  • 1Dept. of Environmental Health Sciences, Johns Hopkins University, Bloomberg School of Public Health, USA; Institute for Work and Health, Universities of Lausanne and Geneva, Switzerland. katherine.clark@hospvd.ch

Regulatory Toxicology and Pharmacology : RTP
|February 12, 2011
PubMed
Summary

Evaluating nanomaterial risks is complex. This study proposes predictive toxicity models to efficiently screen hazardous properties, guiding further toxicological testing and research priorities.

More Related Videos

Electric Cell-Substrate Sensing for Real-Time Evaluation of Metal-Organic Framework Toxicological Profiles
04:53

Electric Cell-Substrate Sensing for Real-Time Evaluation of Metal-Organic Framework Toxicological Profiles

Published on: May 26, 2023

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Related Experiment Videos

Last Updated: Jun 4, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
08:25

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure

Published on: June 5, 2020

Electric Cell-Substrate Sensing for Real-Time Evaluation of Metal-Organic Framework Toxicological Profiles
04:53

Electric Cell-Substrate Sensing for Real-Time Evaluation of Metal-Organic Framework Toxicological Profiles

Published on: May 26, 2023

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster
07:02

Assessment of Chemical Toxicity in Adult Drosophila Melanogaster

Published on: March 24, 2023

Area of Science:

  • Nanotechnology
  • Materials Science
  • Toxicology

Background:

  • Nanomaterial risk assessment is challenging due to diverse physico-chemical properties.
  • Current testing strategies lack rapid and efficient screening for hazard evaluation.
  • Prioritization of toxicological testing for nanomaterials is needed.

Purpose of the Study:

  • To present strategies for developing predictive toxicity models for nanomaterials.
  • To outline an efficient screening approach for nanomaterial hazard evaluation.
  • To highlight the benefits of research focused on predictive toxicology.

Main Methods:

  • Review of strategies for directing research towards predictive models.
  • Discussion of physico-chemical characteristics influencing nanomaterial toxicity.
  • Exploration of ancillary benefits of predictive toxicology research.

Main Results:

  • Predictive toxicity models can integrate physico-chemical properties to forecast hazards.
  • Such models can form a component of a rapid screening approach.
  • Research in this area can inform prioritization for further testing.

Conclusions:

  • Predictive toxicity models are crucial for efficient nanomaterial risk assessment.
  • Developing these models will streamline hazard identification and testing.
  • This approach supports informed decision-making in nanomaterial safety evaluation.